Related Experiment Video
Updated: Jul 12, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Clinical Characteristics of Severe COVID-19 Patients During Omicron Epidemic and a Nomogram Model Integrating
Yanfei Lu1,2, Wenying Xia1,2, Shuxian Miao1,2
1Department of Laboratory Medicine, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, People's Republic of China.
Insights
Severe COVID-19 has a high mortality rate, with cell-free DNA (cfDNA) levels above 97.67 ng/mL significantly increasing risk. A nomogram incorporating age, intubation, shock, cfDNA, and BUN accurately predicts mortality in these patients.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Biomarkers
Background:
- The Omicron variant surge presented challenges in managing severe COVID-19.
- Understanding mortality risk factors and developing predictive tools are crucial for patient outcomes.
Purpose of the Study:
- Investigate clinical characteristics and mortality risk factors in severe COVID-19 patients during the Omicron wave.
- Evaluate the clinical utility of plasma cell-free DNA (cfDNA) as a mortality predictor.
- Develop and validate a nomogram for predicting patient mortality.
Main Methods:
- Retrospective analysis of 282 severe COVID-19 patients (December 2022-January 2023).
- Comparison of clinical data, laboratory indicators, and cfDNA levels between survival and death groups.
- Logistic regression for identifying independent risk factors and nomogram construction using R software.
Main Results:
- Mortality rate was 55.7% in the severe COVID-19 cohort (median age 80).
- Independent risk factors for death included age, tracheal intubation, shock, cfDNA, and blood urea nitrogen (BUN).
- Plasma cfDNA demonstrated strong predictive value (AUC=0.805); the nomogram achieved high accuracy (AUC=0.856).
Conclusions:
- Severe COVID-19 carries a high mortality risk.
- Elevated cfDNA levels (≥97.67 ng/mL) are associated with increased mortality.
- The developed nomogram integrating clinical and cfDNA data offers accurate and consistent mortality prediction.
Objective:
This study aimed to investigate the clinical characteristics and risk factors of death in severe coronavirus disease 2019 (COVID-19) during the epidemic of Omicron variants, assess the clinical value of plasma cell-free DNA (cfDNA), and construct a prediction nomogram for patient mortality.
Methods:
The study included 282 patients with severe COVID-19 from December 2022 to January 2023. Patients were divided into survival and death groups based on 60-day prognosis. We compared the clinical characteristics, traditional laboratory indicators, and cfDNA concentrations at admission of the two groups. Univariate and multivariate logistic analyses were performed to identify independent risk factors for death in patients with severe COVID-19. A prediction nomogram for patient mortality was constructed using R software, and an internal validation was performed.
Results:
The median age of the patients included was 80.0 (71.0, 86.0) years, and 67.7% (191/282) were male. The mortality rate was 55.7% (157/282). Age, tracheal intubation, shock, cfDNA, and urea nitrogen (BUN) were the independent risk factors for death in patients with severe COVID-19, and the area under the curve (AUC) for cfDNA in predicting patient mortality was 0.805 (95% confidence interval [CI]: 0.713-0.898, sensitivity 81.4%, specificity 75.6%, and cut-off value 97.67 ng/mL). These factors were used to construct a prediction nomogram for patient mortality (AUC = 0.856, 95% CI: 0.814-0.899, sensitivity 78.3%, and specificity 78.4%), C-index was 0.856 (95% CI: 0.832-0.918), mean absolute error of the calibration curve was 0.007 between actual and predicted probabilities, and Hosmer-Lemeshow test showed no statistical difference (χ2=6.085, P=0.638).
Conclusion:
There was a high mortality rate among patients with severe COVID-19. cfDNA levels ≥97.67 ng/mg can significantly increase mortality. When predicting mortality in patients with severe COVID-19, a nomogram based on age, tracheal intubation, shock, cfDNA, and BUN showed high accuracy and consistency.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Single Nucleotide Polymorphisms-SNPs

